0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug/Vaccine Safety
 41-60 of 622 Articles
JAMA Oncology | 
Review | 
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA Oncol. 2016;2(4):529-534. doi:10.1001/jamaoncol.2015.5927.
Includes: CME

JAMA Cardiology | 
Original Investigation |  FREE
John A. Dodson, MD, MPH; Andrew Petrone, MPH; David R. Gagnon, MD, MPH, PhD; et al.
JAMA Cardiol. 2016;1(1):65-72. doi:10.1001/jamacardio.2015.0345.
Includes: Supplemental Content

JAMA Ophthalmology | 
Original Investigation | 
Katherine Duncan, MD; Jeff Parker, BS, MT(ASCP); Caroline Hoover, CEBT; et al.
JAMA Ophthalmol. 2016;134(4):432-436. doi:10.1001/jamaophthalmol.2016.0008.

JAMA Internal Medicine | 
Editorial | 
Steven Woloshin, MD, MS; Lisa M. Schwartz, MD, MS
JAMA Intern Med. 2016;176(4):439-442. doi:10.1001/jamainternmed.2016.0073.

JAMA Internal Medicine | 
Original Investigation | 
Loes Jaspers, MD; Frederik Feys, MSc, PhD; Wichor M. Bramer, BSc; et al.
JAMA Intern Med. 2016;176(4):453-462. doi:10.1001/jamainternmed.2015.8565.
Includes: CME, Supplemental Content

JAMA Pediatrics | 
Original Investigation | 
Jean-Michel Hascoët, MD; Jean-Charles Picaud, MD, PhD; Isabelle Ligi, MD; et al.
JAMA Pediatr. 2016;170(4):365-372. doi:10.1001/jamapediatrics.2015.4617.
Includes: Supplemental Content

JAMA Internal Medicine | 
Invited Commentary | 
Jeffrey L. Schnipper, MD, MPH
JAMA Intern Med. 2016;176(4):471-472. doi:10.1001/jamainternmed.2015.8562.

JAMA Internal Medicine | 
Original Investigation | 
Ajit A. Dhavle, PharmD, MBA; Yuze Yang, PharmD; Michael T. Rupp, PhD; et al.
JAMA Intern Med. 2016;176(4):463-470. doi:10.1001/jamainternmed.2015.7786.

JAMA Oncology | 
Original Investigation | 
Nicholas D. James, PhD, FRCR, FRCP; Sarah J. Pirrie, MSc; Ann M. Pope, PhD; et al.
JAMA Oncol. 2016;2(4):493-499. doi:10.1001/jamaoncol.2015.5570.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Michael Kolinsky, BSc, MD; Pasquale Rescigno, MD; Johann S. de Bono, MB, ChB, MSc, FRCP, PhD, FMedSci
JAMA Oncol. 2016;2(4):437-438. doi:10.1001/jamaoncol.2015.4918.

JAMA Oncology | 
Invited Commentary | 
Saroj Niraula, MBBS, MD, MSc; Ian F. Tannock, MD, PhD
JAMA Oncol. 2016;2(4):461-462. doi:10.1001/jamaoncol.2015.4682.

JAMA Oncology | 
Original Investigation | 
Dawn L. Hershman, MD, MS; Joseph M. Unger, PhD; Jason D. Wright, MD; et al.
JAMA Oncol. 2016;2(4):453-461. doi:10.1001/jamaoncol.2015.4655.
Includes: Supplemental Content

JAMA Surgery | 
Research Letter | 
William Toppen, BA; Sohail Sareh, MS; Daniel Johansen, BA; et al.
JAMA Surg. 2016;151(4):389-391. doi:10.1001/jamasurg.2015.4212.

JAMA Pediatrics | 
Research Letter |  ONLINE FIRST
Paul L. Delamater, PhD; Timothy F. Leslie, PhD; Y. Tony Yang, ScD, LLM, MPH
JAMA Pediatr. Published online March 28, 2016. doi:10.1001/jamapediatrics.2015.4856

JAMA Dermatology | 
Research Letter |  ONLINE FIRST
Simone M. Goldinger, MD; Sharon Gobbi Bischof, MD; Regina Fink-Puches, MD; et al.
JAMA Dermatol. Published online March 23, 2016. doi:10.1001/jamadermatol.2016.0401

JAMA Dermatology | 
Research Letter |  ONLINE FIRST
Kiyanna Williams, BS; Sarah T. Arron, MD, PhD
JAMA Dermatol. Published online March 16, 2016. doi:10.1001/jamadermatol.2016.0351

JAMA | 
Capitol Health Call | 
Rita Rubin, MA
JAMA. 2016;315(10):970. doi:10.1001/jama.2016.1783.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2016;315(10):971. doi:10.1001/jama.2016.1631.

JAMA Oncology | 
Editorial |  ONLINE FIRST
Gary H. Lyman, MD, MPH
JAMA Oncol. Published online March 03, 2016. doi:10.1001/jamaoncol.2015.6477

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Ariadna Tibau, MD; Alberto Ocana, MD, PhD; Geòrgia Anguera, MD; et al.
JAMA Oncol. Published online March 03, 2016. doi:10.1001/jamaoncol.2015.6479
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression A Subgroup Analysis of a Randomized Clinical Trial
Saby George, MD; Robert J. Motzer, MD; Hans J. Hammers, MD, PhD; et al.
JAMA
Medical News & Perspectives  | 
FDA’s Foray Into Big Data Still Maturing
Bridget M. Kuehn, MSJ
JAMA Internal Medicine
Editorial  | 
Promise and Peril for Generic Drugs
Joshua M. Sharfstein, MD; Jeremy Greene, MD, PhD
JAMA Internal Medicine
Research Letter  | 
Prevalence and Predictors of Generic Drug Skepticism Among Physicians Results of a National Survey
Aaron S. Kesselheim, MD, JD, MPH; Joshua J. Gagne, PharmD, ScD; Wesley Eddings, PhD; et al.